Myopia
Conditions
Interventions
PDSLpm:Peripheral defocus spectacle lenses(DIMS or HALT)
ATP:0.01% atropine eye drops
Myopic eye defocus frame lens group:Peripheral defocus spectacle lenses(DIMS or HALT)
OK:OK lens(Alpha or iBright)
Myopia combination treatment group:Combined peripheral defocus spectacle lenses and 0.01% atropine eye drops
Sponsors
Zhujiang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Diagnosed refractive error (myopia or pre-myopia), astigmatism = 0.8; 2.During the observation period, same intervention was consistently used for >= 12 months; 3.baseline and 12-month-follow up data were completed.
Exclusion criteria
Exclusion criteria: 1.Presence of ocular diseases such as strabismus (except heterophoria), amblyopia, keratoconus, glaucoma, or fundus disorders (e.g., history of retinal detachment); 2.Concurrent use of other myopia control interventions (e.g., defocus soft contact lenses, red light therapy devices) during or within 3 months prior to the study; 3.Systemic diseases affecting refractive development (e.g., Marfan syndrome, diabetes).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Axial length; | — |
Countries
China
Contacts
Public ContactLin Shunchao
Zhujiang Hospital of Southern Medical University
Outcome results
None listed